Summit starts in

17–18 September 2026 · Bristol

Speakers and chairs

Voices from across research, services, policy and lived experience, speaking and chairing sessions across the two days.

Day 1 — Thursday 17 September

M Shed
Philippe Bonnet

Philippe Bonnet

Harm Reduction Coordinator – Birmingham, The Hepatitis C Trust

Alternative NSP Delivery

Mark Roberts

Mark Roberts

Peer Coordinator – North East & North Cumbria, The Hepatitis C Trust

To be confirmed

Mark Napier

Mark Napier

Managing Director, The Centre for Public Innovation

Understanding NSP provision in London – findings from a mapping exercise

Farrah Hart

Farrah Hart

Consultant in Public Health, Greater London Authority

Understanding NSP provision in London – findings from a mapping exercise

Monica Desai

Monica Desai

Consultant Epidemiologist and Head of the Hepatitis Section, UK Health Security Agency

The National Picture

[photo]

Amelia Andrews

Principal Scientist, Drugs & Infections team, UK Health Security Agency

The National Picture

Niamh Eastwood

Niamh Eastwood

Executive Director, Release

Uncracking the legality of paraphernalia laws: the case for reform

Cara Lavan

Cara Lavan

Councillor for St George Central ward, Bristol, Bristol City Council (Green Party) · Transform Drug Policy Foundation

To be confirmed

Catherine Cook

Catherine Cook

Executive Director, Harm Reduction International (HRI)

Protecting Progress: Harm Reduction, Hepatitis C Elimination and the UK’s Global Leadership

Jenny Scott (she/her)

Jenny Scott (she/her)

Senior Lecturer and Pharmacist Prescriber, Centre for Academic Primary Care, University of Bristol · Turning Point

Session chair

Chairing a session

Seba (she/they)

Seba (she/they)

Welfare & Trans Harm Reduction Specialist Worker, Safe Only CIC

What can we learn from Queer Community Harm Reduction Practices?

[photo]

Clyne Hamilton-Daniels (he/him)

Doctoral Researcher in Public Health & Policy, Queen Mary University of London

Pleasure, Platforms and Public Health: Rethinking Harm Reduction in Chemsex

Shayla Schlossenberg (they/them)

Shayla Schlossenberg (they/them)

Head of Drugs Services, Release

Session chair

Chairing a session

Day 2 — Friday 18 September

Bristol Beacon
Isabelle Boisvert (she/her)

Isabelle Boisvert (she/her)

Researcher & Partnerships Lead with Lived Experience, CRCHUM / CRISM – Quebec Node

Peer-Led Strategies for Equitable Engagement of People Who Use Drugs in Care and Research

Peter Furlong

Peter Furlong

National Harm Reduction Lead, Change Grow Live

Why we need separate, and separately funded, harm reduction and treatment services

Chris Rintoul

Chris Rintoul

Head of Harm Reduction, Cranstoun

Why we need separate, and separately funded, harm reduction and treatment services

Adam Holland (he/him)

Adam Holland (he/him)

Public Health Researcher / Public Health Consultant (FFPH), University of Bristol

‘Drugs: It’s Complicated’ – Co-developing and Evaluating Films Intended to Reduce Stigma Towards People Who Use Criminalised Drugs

Victoria (Vicki) Beere

Victoria (Vicki) Beere

PhD Candidate, University of Manchester

We are Fearless Women: Examining the Impact of New Public Management on Women’s Access to Harm Reduction Services in England

Dilesh Popat

Dilesh Popat

National Diverse Communities Lead, Turning Point

Breaking Barriers, Not Building Services Around Them — A Community Approach to Harm Reduction

Prun Bijral (he/him)

Prun Bijral (he/him)

Executive Medical Director, Change Grow Live

Optimising Opioid Medication-Assisted Treatment: Reducing Drug-Related Harm through the AAAQ Framework

Rebecca Bulmer

Rebecca Bulmer

Senior Peer Educator / Peer Researcher, The Hepatitis C Trust

The Power of Peer Research